CRP and atherosclerosis: Thus, our current findings using mutant CRP and previous findings using monomeric CRP, both molecules capable of binding to atherogenic LDL, indicate that structurally altered CRP protects against atherosclerosis; it is just that WT CRP does not exert a protective effect in most animal models (25, 44).